Pharma Mar, S.A.

PHMMF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$5$23-$4$10
Dep. & Amort.$2$2$2$2
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0-$0
Change in WC$58-$26-$8-$12
Other Non-Cash-$36$9$4$2
Operating Cash Flow$20$9-$6$2
Investing Activities
PP&E Inv.-$1-$1-$1-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$196-$103-$68-$90
Inv. Sales/Matur.$0$78$80$112
Other Inv. Act.-$179$0$0$0
Investing Cash Flow$15-$27$11$20
Financing Activities
Debt Repay.-$2-$0$1-$0
Stock Issued-$2$1$1$16
Stock Repurch.$2-$7-$8-$9
Dividends Paid$0-$14$0$0
Other Fin. Act.$0-$0-$0-$3
Financing Cash Flow-$2-$20-$7$4
Forex Effect$1-$1-$1$2
Net Chg. in Cash$33-$39-$3$28
Supplemental Information
Beg. Cash$25$60$63$35
End Cash$58$22$60$63
Free Cash Flow$18$8-$7-$0